Changes in Mumps Virus Gene Sequence Associated with Variability in Neurovirulent Phenotype

Journal of Virology

Volumn 77, Issue 21, 2003, Pages 11616-11624

  Rubin, Steven A ^a,c   Amexis, Georgios ^a   Pletnikov, Mikhail ^b   Vanderzanden, Jacqueline ^a   Mauldin, Jeremy ^a   Sauder, Christian ^a   Malik, Tahir ^a   Chumakov, Konstantin ^a   Carbone, Kathryn M ^a,b  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; DNA DIRECTED DNA POLYMERASE ALPHA; HN PROTEIN; HYBRID PROTEIN; JERYL LYNN VACCINE; MATRIX PROTEIN; MUMPS VACCINE; NUCLEOPROTEIN; UNCLASSIFIED DRUG; VIRUS VACCINE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; CHICKEN; CONTROLLED STUDY; DISEASE MODEL; FIBROBLAST; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; JERYL LYNN VIRUS VARIANT; MUMPS VIRUS; MUMPS VIRUS STRAIN 88 1961; MUMPS VIRUS STRAIN 88 1961 CEF; MUMPS VIRUS STRAIN JL SY5Y; MUMPS VIRUS STRAIN JL VERO; NERVE CELL; NEUROTROPISM; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; RAT; SEQUENCE ANALYSIS; UNITED STATES; VIRUS MENINGITIS; VIRUS REPLICATION; VIRUS STRAIN; VIRUS VIRULENCE; WILD TYPE;

AMINO ACID SEQUENCE; ANIMALS; BRAIN; CELL LINE; CENTRAL NERVOUS SYSTEM VIRAL DISEASES; CERCOPITHECUS AETHIOPS; CYTOPATHOGENIC EFFECT, VIRAL; DISEASE MODELS, ANIMAL; HUMANS; MUMPS; MUMPS VACCINE; MUMPS VIRUS; NEURONS; PHENOTYPE; RATS; RATS, INBRED LEW; VACCINES, ATTENUATED; VARIATION (GENETICS); VERO CELLS; VIRULENCE; VIRUS REPLICATION;

EID: 0142060847     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.21.11616-11624.2003     Document Type: Article

References (60)

1. Afzal, M. A., A. R. Pickford, T. Forsey, A. B. Heath, and P. D. Minor. 1993 The Jeryl Lynn vaccine strain of mumps virus is a mixture of two distinct isolates. J. Gen. Virol. 74:917-920.
2. Afzal, M. A., P. J. Yates, and P. D. Minor. 1998. Nucleotide sequence at position 1081 of the hemagglutinin-neuraminidase gene in the mumps Urabe vaccine strain. J. Infect. Dis. 177:265-266.
3. Amexis, G., S. Rubin, N. Chatterjee, K. Carbone, and K. Chumakov. 2003. Identification of a new genotype H wild-type mumps virus strain and its molecular relatedness to other virulent and attenuated strains. J. Med. Virol. 70:284-286.
4. Amexis, G., S. A. Rubin, V. Chizhikov, F. Pelloquin, K. M. Carbone, and K. M. Chumakov. 2002. Sequence diversity of Jeryl Lynn strain of mumps virus: quantitative mutant analysis for vaccine quality control. Virology 300:171-179.
5. Balraj, V., and E. Miller. 1995. Complications of mumps vaccines. Rev. Med. Virol. 5:219-227.
6. Bang, H. O., and J. Bang. 1943. Involvement of the central nervous system in mumps. Acta Med. Scand. 113:487-505.
7. Bhaiyat, M. I., Y. Kobayashi, C. Itakura, M. A. Islam, and H. Kida. 1995. Brain lesions in chickens experimentally infected with a neuroadapted strain of mesogenic Newcastle disease virus. J Vet. Med. Sci. 57:237-244.
8. Brown, E. G., K. Dimock, and K. E. Wright. 1996. The Urabe AM9 mumps vaccine is a mixture of viruses differing at amino acid 335 of the hemagglutinin-neuraminidase gene with one form associated with disease. J. Infect. Dis. 174:619-622.
9. Buynak, E. B., and M. R. Hilleman. 1966. Live attenuated mumps virus vaccine. 1. Vaccine development. Proc. Soc. Exp. Biol. Med. 123:768-775.
10. Carbone, K. M., and J. S. Wolinsky. 2001. Mumps virus, p. 1381-1400. In D. M. Knipe and P. M. Howley (ed.), Fields virology. Lippincott-Raven, Philadelphia, Pa.
11. Cavallaro, J. J., and H. F. Maassab. 1966. Adaptation of respiratory syncytial (RS) virus to brain of suckling mice. Proc. Soc. Exp. Biol. Med. 121:37-41.
12. Cohen, H. A., A. Ashkenazi, M. Nussinovitch, J. Amir, J. Hart, and M. Frydman. 1992. Mumps-associated acute cerebellar ataxia. Am. J. Dis. Child. 146:930-931.
13. Connaris, H., T. Takimoto, R. Russell, S. Crennell, I. Moustafa, A. Portner, and G. Taylor. 2002. Probing the sialic acid binding site of the hemagglutinin-neuraminidase of Newcastle disease virus: identification of key amino acids involved in cell binding, catalysis, and fusion. J. Virol. 76:1816-1824.
14. Cortese, C. K., J. A. Feller, and S. A. Moyer. 2000. Mutations in domain V of the Sendai virus L polymerase protein uncouple transcription and replication and differentially affect replication in vitro and in vivo. Virology 277:387-396.
15. Crennell, S., T. Takimoto, A. Portner, and G. Taylor. 2000. Crystal structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase. Nat. Struct. Biol. 7:1068-1074.
16. Elango, N., T. M. Varsanyi, J. Kovamees, and E. Norrby. 1988. Molecular cloning and characterization of six genes, determination of gene order and intergenic sequences and leader sequence of mumps virus. J. Gen. Virol. 69:2893-2900.
17. Enders, J. F., F. C. Robbins, and T. H. Weller. 1980. Classics in infectious disease. The cultivation of the poliomyelitis viruses in tissue culture by John F. Enders, Frederick C. Robbins, and Thomas H. Weller. Rev. Infect. Dis. 2:493-504.
18. Enders, J. F., T. H. Weller, and F. C. Robbins. 1949. Cultivation of the Lansing strain of poliomyelitis virus in cultures of various human embryonic tissues. Science 109:85-87.
19. Faaberg, K. S., G. A. Palmer, C. Even, G. W. Anderson, and P. G. Plagemann. 1995. Differential glycosylation of the ectodomain of the primary envelope glycoprotein of two strains of lactate dehydrogenase-elevating virus that differ in neuropathogenicity. Virus Res. 39:331-340.
20. Hall, R., and H. Richards. 1987. Hearing loss due to mumps. Arch. Dis. Child. 62:189-191.
21. Herndon, R. M., R. T. Johnson, L. E. Davis, and L. R. Descalzi. 1974. Ependymitis in mumps virus meningitis: electron microscopical studies of cerebrospinal fluid. Arch. Neurol. 30:475-479.
22. Hilleman, M. R., E. B. Buynak, R. E. Weibel, and J. Stokes. 1968. Live, attenuated mumps-virus vaccine. N. Engl. J. Med. 278:227-232.
23. Immunization Practices Advisory Committee. 1997. Mumps prevention. Morb. Mortal. Wkly. Rep. 38:397-400.
24. Jackson, A. C., T. R. Moench, B. D. Trapp, and D. E. Griffin. 1988. Basis of neurovirulence in Sindbis virus encephalomyelitis of mice. Lab. Investig. 58:503-509.
25. Johansson, B., T. Tecle, and C. Orvell. 2002. Proposed criteria for classification of new genotypes of mumps virus. Scand. J. Infect. Dis. 34:355-357.
26. Johnson, K. P., and R. T. Johnson. 1972. Granular ependymitis: occurrence in myxovirus infected rodents and prevalence in man. Am. J. Pathol. 67:511-526.
27. Johnson, R. T., and K. P. Johnson. 1969. Hydrocephalus as a sequela of experimental myxovirus infections. Exp. Mol. Pathol. 10:68-80.
28. Johnson, R. T., K. P. Johnson, and C. J. Edmonds. 1967. Virus-induced hydrocephalus: development of aqueductal stenosis in hamsters after mumps infection. Science 157:1066-1067.
29. Kilham, L., J. Levens, and J. F. Enders. 1949. Nonparalytic poliomyelitis and mumps meningoencephalitis. Differential diagnosis. JAMA 140:934-936.
30. Kobune, K., F. Kobune, K. Yamanouchi, K. Nagashima, Y. Yoshikawa, and M. Hayami. 1983. Neurovirulence of rat brain-adapted measles virus. Jpn. J. Exp. Med. 53:177-180.
31. Koskiniemi, M., M. Donner, and O. Pettay. 1983. Clinical appearance and outcome in mumps encephalitis in children. Acta Paediatr. Scand. 72:603-609.
32. Kövamees, J., R. Rydbeck, C. Örvell, and E. Norrby. 1990. Hemagglutininneuraminidase (HN) amino acid alterations in neutralization escape mutants of Kilham mumps virus. Virus Res. 17:119-130.
33. Lennette, E. H., G. E. Caplan, and R. L. Magoffin. 1960. Mumps virus infection simulating paralytic poliomyelitis. A report of 11 cases. Paediatrics 25:788-797.
34. Li, S., J. Schulman, S. Itamura, and P. Palese. 1993. Glycosylation of neuraminidase determines the neurovirulence of influenza A/WSN/33 virus. J. Virol. 67:6667-6673.
35. Love, A., R. Rydbeck, K. Kristensson, C. Örvell, and E. Norrby. 1985. Hemagglutinin-neuraminidase glycoprotein as a determinant of pathogenicity in mumps virus hamster encephalitis: analysis of mutants selected with monoclonal antibodies. J. Virol. 53:67-74.
36. McKenna, M. 1997. Measles, mumps, and sensorineural hearing loss. Ann. N. Y. Acad. Sci. 830:291-298.
37. Minor, P. D. 1997. Laboratory tests of mumps vaccines. Biologicals 25:35-40.
38. Modlin, J. F., W. A. Orenstein, and A. D. Brandling-Bennett. 1975. Current status of mumps in the United States. J. Infect. Dis. 132:106-109.
39. Muylaert, I. R., T. J. Chambers, R. Galler, and C. M. Rice. 1996. Mutagenesis of the N-linked glycosylation sites of the yellow fever virus NS1 protein: effects on virus replication and mouse neurovirulence. Virology 222:159-168.
40. Nishino, Y., D. Kobasa, S. A. Rubin, M. V. Pletnikov, and K. M. Carbone. 2002. Enhanced neurovirulence of Borna disease virus variants associated with nucleotide changes in the glycoprotein and L polymerase genes. J. Virol. 76:8650-8658.
41. Ogata, H., K. Oka, and A. Mitsudome. 1992. Hydrocephalus due to acute aqueductal stenosis following mumps infection: report of a case and review of the literature. Brain Dev. 14:417-419.
42. Poch, O., B. M. Blumberg, L. Bougueleret, and N. Tordo. 1990. Sequence comparison of five polymerases (L proteins) of unsegmented negative-strand RNA viruses: theoretical assignment of functional domains. J. Gen. Virol. 71:1153-1162.
43. Rubin, S. A., M. Pletnikov, and K. M. Carbone. 1998. Comparison of the neurovirulence of a vaccine and a wild-type mumps virus strain in the developing rat brain. J. Virol. 72:8037-8042.
44. Rubin, S. A., M. Pletnikov, R. Taffs, P. J. Snoy, D. Kobasa, E. G. Brown, K. E. Wright, and K. M. Carbone. 2000. Evaluation of a neonatal rat model for prediction of mumps virus neurovirulence in humans. J. Virol. 74:5382-5384.
45. Schlesinger, J. J., S. Chapman, A. Nestorowicz, C. M. Rice, T. E. Ginocchio, and T. J. Chambers. 1996. Replication of yellow fever virus in the mouse central nervous system: comparison of neuroadapted and non-neuroadapted virus and partial sequence analysis of the neuroadapted strain. J. Gen. Virol. 77:1277-1285.
46. Sidhu, M. S., J. P. Menonna, S. D. Cook, P. C. Dowling, and S. A. Udem. 1993. Canine distemper virus L gene: sequence and comparison with related viruses. Virology 193:50-65.
47. Smeenk, C. A., and E. G. Brown. 1994. The influenza virus variant A/FM/1/47-MA possesses single amino acid replacements in the hemagglutinin, controlling virulence, and in the matrix protein, controlling virulence as well as growth. J. Virol. 68:530-534.
48. Stuart-Harris, C. 1939. A neurotropic strain of human influenza virus. Lancet i.497-499.
49. Stubley-Weatherly, L., J. W. Harding, and J. W. Wright. 1996. Effects of discrete kainic acid-induced hippocampal lesions on spatial and contextual learning and memory in rats. Brain Res. 716:29-38.
50. Takano, T., Y. Mekata, T. Yamano, and M. Shimada. 1993. Early ependymal changes in experimental hydrocephalus after mumps virus inoculation in hamsters. Acta Neuropathol. 85:521-525.
51. Takano, T., S. Takikita, and M. Shimada. 1999. Experimental mumps virus-induced hydrocephalus: viral neurotropism and neuronal maturity. Neuro-Report 10:2215-2221.
52. Takano, T., M. Uno, T. Yamano, and M. Shimada. 1994. Pathogenesis of cerebellar deformity in experimental Chiari type I malformation caused by mumps virus. Acta Neuropathol. 87:168-173.
53. Takeuchi, K., K. Tanabayashi, M. Hishiyama, A. Yamada, and A. Sugiura. 1989. Cloning and sequencing of the fusion protein gene of mumps virus (Miyahara strain). Nucleic Acids Res. 17:5839.
54. Tecle, T., B. Bottiger, C. Orvell, and B. Johansson. 2001. Characterization of two decades of temporal co-circulation of four mumps virus genotypes in Denmark: identification of a new genotype. J. Gen. Virol. 82:2675-2680.
55. Timmons, G. D., and K. P. Johnson. 1970. Aqueductal stenosis and hydrocephalus after mumps encephalitis. N. Engl. J. Med. 283:1505-1507.
56. Ward, A. C. 1996. Neurovirulence of influenza A virus. J. Neurovirol. 2:139-151.
57. Westmore, G. A., B. H. Pickard, and H. Stern. 1979. Isolation of mumps virus from the inner ear after sudden deafness. Br. Med. J. 1:14-15.
58. Wolinsky, J. S., J. R. Baringer, G. Margolis, and L. Kilham. 1974. Ultrstructure of mumps virus replication in newborn hamster central nervous system. Lab. Investig. 31:403-412.
59. Wu, X., X. Gong, H. D. Foley, M. J. Schnell, and Z. F. Fu. 2002. Both viral transcription and replication are reduced when the rabies virus nucleoprotein is not phosphorylated. J. Virol. 76:4153-4161.
60. Ye, Z. P., R. Pal, J. W. Fox, and R. R. Wagner. 1987. Functional and antigenic domains of the matrix (M1) protein of influenza A virus. J. Virol. 61:239-246.